Lantus and Tamiflu expired in patent on February
On February, Lantus and Tamiflu will expired in patent.
First of all, the Sanofi’s antidiabetic treatments, Lantus Inj Vial, Lantus Inj Solostar and Lantus Inj Cartridge, have been expired in their substance and use patents since the 6th.
Their PMS expiration data was 5 February 2010, and their...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.